Milestone Cash Conversion Cycle from 2010 to 2026

Stocks . USA . 
Stock . Milestone Scientific
MLSS Stock  USD 0.29  -0.002  -0.69%   
Long-term reporting places Cash Conversion Cycle within a firming cycle. It is projected to reach 441.93 this year. From 2010 to 2026, regression modeling of Milestone Scientific Cash Conversion Cycle demonstrates a geometric mean of 139.50 . alongside coefficient of variation of 152.97 . View All Fundamentals
 
Cash Conversion Cycle  
 First Reported
2010-12-31
 Previous Quarter
420.89
 Current Value
441.93
 Quarterly Volatility
231.60674707
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
This statements view for Milestone Scientific organizes long-term performance signals with capital structure context. The series highlights drivers like Depreciation And Amortization of 32 K, Interest Expense of 59.7 K or Selling General Administrative of 8.7 M and ratios such as Price To Sales Ratio of 9.7, Dividend Yield of 0.0 or PTB Ratio of 18.14, complementing Milestone Scientific Valuation and Volatility.
  
Build AI portfolio with Milestone Stock
Milestone Scientific Correlation provides competitor comparison context for Milestone Scientific. This supports competitive context.
To understand the process of investing in Milestone Stock, visit our How to Invest in Milestone Scientific guide.
The evolution of Cash Conversion Cycle for Milestone Scientific provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Milestone Scientific compares to historical norms and industry peers.

Latest Milestone Scientific's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of Milestone Scientific over the last few years. It is Milestone Scientific's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Milestone Scientific's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Slightly volatile
Compare to OthersAll Fundamentals
   Cash Conversion Cycle   
       Timeline  

Milestone Cash Conversion Cycle Regression Statistics

Arithmetic Mean 151.40
Geometric Mean 139.50
Coefficient Of Variation 152.97
Mean Deviation 193.85
Median 159.32
Standard Deviation 231.61
Sample Variance 53,642
Range797
R-Value 0.62
Mean Square Error 35,205
R-Squared 0.38
Significance 0.01
Slope 28.45
Total Sum of Squares 858,267

Milestone Cash Conversion Cycle History

2026 441.93
2025 420.89
2024 467.65
2023 196.6
2022 18.11
2021 66.8
2020 384.51

Stock Overview, Methodology & Data Sources

Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey. Milestone Scientific operates under Medical Instruments Supplies classification in the United States and is traded on AMEX Exchange. It employs 26 people. Liquidity and trading activity can influence how quickly new information is reflected in Milestone Scientific's price. Lower trading activity may introduce occasional variability in execution conditions. Milestone Scientific has a market cap of 22.65 M, ROE of -136.47%.

Methodology

Unless otherwise specified, financial data for Milestone Scientific is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Milestone (USA Stocks:MLSS) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for Milestone Scientific is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Milestone Scientific may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on February 28th, 2026

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Milestone Stock Analysis

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY